Vi Polysaccharide Typhoid Vaccine(Zhejiang Tianyuan)

伤寒Vi多糖疫苗（浙江天元）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameVi Polysaccharide Typhoid Vaccine(Zhejiang Tianyuan)
Drug Alias NameN/A
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Inactivated vaccine > Split vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsTyphoid Fever
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesZhejiang Tianyuan Bio-Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesZhejiang Tianyuan Bio-Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsTyphoid Fever
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A